466 related articles for article (PubMed ID: 29096391)
41. Rare and emerging viral infections in transplant recipients.
Waggoner JJ; Soda EA; Deresinski S
Clin Infect Dis; 2013 Oct; 57(8):1182-8. PubMed ID: 23839998
[TBL] [Abstract][Full Text] [Related]
42. Cutaneous malignancies in immunosuppressed organ transplant recipients.
Seda IM; Zubair A; Brewer JD
Skinmed; 2014; 12(3):164-73. PubMed ID: 25134313
[TBL] [Abstract][Full Text] [Related]
43. Phaeohyphomycosis due to Exophiala infections in solid organ transplant recipients: Case report and literature review.
Oberlin KE; Nichols AJ; Rosa R; Dejman A; Mattiazzi A; Guerra G; Elgart GW; Abbo LM
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28500778
[TBL] [Abstract][Full Text] [Related]
44. Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients.
Savoia P; Ranghino A; Fava P
Curr Drug Targets; 2017; 18(4):436-446. PubMed ID: 26758664
[TBL] [Abstract][Full Text] [Related]
45. The cutting edge of skin cancer in transplant recipients: scientific retreat of international transplant Skin Cancer Collaborative and Skin Cancer in Organ Transplant Patients Europe.
Hanlon A; Colegio OR
Am J Transplant; 2014 May; 14(5):1012-5. PubMed ID: 24612476
[TBL] [Abstract][Full Text] [Related]
46. Adenovirus infections in solid organ transplant recipients.
Hoffman JA
Curr Opin Organ Transplant; 2009 Dec; 14(6):625-33. PubMed ID: 19741532
[TBL] [Abstract][Full Text] [Related]
47. Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature.
Džambová M; Sečníková Z; Jiráková A; Jůzlová K; Viklický O; Hošková L; Göpfertovà D; Hercogová J
Dermatol Ther; 2016; 29(1):64-8. PubMed ID: 26460720
[TBL] [Abstract][Full Text] [Related]
48. Skin infections in organ transplant recipients.
Ulrich C; Hackethal M; Meyer T; Geusau A; Nindl I; Ulrich M; Forschner T; Sterry W; Stockfleth E
J Dtsch Dermatol Ges; 2008 Feb; 6(2):98-105. PubMed ID: 17995969
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility of solid organ transplant recipients to viral pathogens with zoonotic potential: A mini-review.
Bezerra KC; Vieira CMAG; de Oliveira-Filho EF; Reis CRS; Oriá RB
Braz J Infect Dis; 2024; 28(2):103742. PubMed ID: 38670166
[TBL] [Abstract][Full Text] [Related]
50. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment.
Kim C; Cheng J; Colegio OR
Semin Oncol; 2016 Jun; 43(3):390-4. PubMed ID: 27178693
[TBL] [Abstract][Full Text] [Related]
52. Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
Skillen LA; Corry A
Clin Exp Dermatol; 2019 Jan; 44(1):62-63. PubMed ID: 30430627
[No Abstract] [Full Text] [Related]
53. Respiratory viral infections in transplant and oncology patients.
Kumar D; Humar A
Infect Dis Clin North Am; 2010 Jun; 24(2):395-412. PubMed ID: 20466276
[TBL] [Abstract][Full Text] [Related]
54. A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients.
Suresh S; Lee BE; Robinson JL; Akinwumi MS; Preiksaitis JK
Pediatr Transplant; 2016 Nov; 20(7):970-980. PubMed ID: 27565955
[TBL] [Abstract][Full Text] [Related]
55. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
56. Infection in solid-organ transplant recipients.
Fishman JA
N Engl J Med; 2007 Dec; 357(25):2601-14. PubMed ID: 18094380
[No Abstract] [Full Text] [Related]
57. Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.
McCarty TP; Lee RA; Herfel BM; Pappas PG
J Clin Virol; 2015 May; 66():48-50. PubMed ID: 25866336
[TBL] [Abstract][Full Text] [Related]
58. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
[TBL] [Abstract][Full Text] [Related]
59. No association between infections, HLA type and other transplant-related factors and risk of cutaneous squamous cell carcinoma in solid organ transplant recipients.
Ingvar Å; Ekström Smedby K; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Acta Derm Venereol; 2012 Nov; 92(6):609-14. PubMed ID: 22293782
[TBL] [Abstract][Full Text] [Related]
60. Dermatological Complications After Solid Organ Transplantation.
Naldi L; Venturuzzo A; Invernizzi P
Clin Rev Allergy Immunol; 2018 Feb; 54(1):185-212. PubMed ID: 29177692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
